{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T05:47:07Z","timestamp":1724910427428},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:p>The association of bullous pemphigoid with melanoma remains controversial and poorly understood. Recent studies report the presence of the bullous pemphigoid antigen, BP180, in melanoma cells, yet not normal melanocytes, suggesting an underlying mechanism for cases of melanoma-associated bullous pemphigoid. We report on an 88-year-old woman who showed a temporal relationship between the development of bullous pemphigoid and melanoma. The patient did not receive programmed death ligand 1 inhibitor therapy and improved rapidly following complete excision of her melanoma, with clobetasol, doxycycline, and niacinamide. We review the literature on the relationship between bullous pemphigoid and melanoma, and propose a mechanism underlying a melanoma-associated bullous pemphigoid.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000307","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T10:21:28Z","timestamp":1476872488000},"page":"65-67","source":"Crossref","is-referenced-by-count":9,"title":["A case report of bullous pemphigoid associated with a melanoma and review of the literature"],"prefix":"10.1097","volume":"27","author":[{"given":"Kyle T.","family":"Amber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Panganiban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Korta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien de","family":"Feraudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei A.","family":"Grando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230902","first-page":"225","article-title":"Pemphigoid with malignant melanoma","volume":"54","author":"Marks","year":"1961","journal-title":"Proc R Soc Med"},{"key":"R2-20230902","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/bjc.1968.79","article-title":"Pemphigoid and malignancy","volume":"22","author":"Parsons","year":"1968","journal-title":"Br J Cancer"},{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4103\/0378-6323.168353","article-title":"Bullous pemphigoid with malignant melanoma","volume":"81","author":"Parimi","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R4-20230902","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40425-016-0123-3","article-title":"Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid","volume":"4","author":"Beck","year":"2016","journal-title":"J Immunother Cancer"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00418-012-0981-9","article-title":"Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis","volume":"138","author":"Krenacs","year":"2012","journal-title":"Histochem Cell Biol"},{"key":"R6-20230902","doi-asserted-by":"crossref","first-page":"e10566","DOI":"10.1371\/journal.pone.0010566","article-title":"Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma","volume":"5","author":"Shimbo","year":"2010","journal-title":"PLoS One"},{"key":"R7-20230902","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CMR.0000000000000189","article-title":"Serum anti-BPAG1 autoantibody level is not a useful biomarker for cutaneous melanoma","volume":"26","author":"Gambichler","year":"2016","journal-title":"Melanoma Res"},{"key":"R8-20230902","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-1759(96)00167-6","article-title":"Rapid direct determination of HLA-DQB1 * 0301 in the whole blood of normal individuals and cancer patients by specific polymerase chain reaction amplification","volume":"199","author":"Lu","year":"1996","journal-title":"J Immunol Methods"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1399-0039.1998.tb03025.x","article-title":"HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population","volume":"52","author":"Bateman","year":"1998","journal-title":"Tissue Antigens"},{"key":"R10-20230902","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J Clin Invest"},{"key":"R11-20230902","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","article-title":"A population-based study of the association between bullous pemphigoid and neurologic disorders","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2007.04.073","article-title":"Distribution of collagen XVII in the human brain","volume":"1158","author":"Seppanen","year":"2007","journal-title":"Brain Res"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","article-title":"The association of bullous pemphigoid with cerebrovascular disease and dementia: a case\u2013control study","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol"},{"key":"R14-20230902","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jid.2015.12.005","article-title":"Autoantibodies to collagen XVII are present in Parkinson\u2019s disease and localize to tyrosine-hydroxylase positive neurons","volume":"136","author":"Messingham","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R15-20230902","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/bjd.14538","article-title":"Parkinson\u2019s disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction","volume":"175","author":"Recke","year":"2016","journal-title":"Br J Dermatol"},{"key":"R16-20230902","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/cup.12717","article-title":"Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions","volume":"43","author":"Jour","year":"2016","journal-title":"J Cutan Pathol"},{"key":"R17-20230902","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/CMR.0000000000000260","article-title":"Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies","volume":"26","author":"Hwang","year":"2016","journal-title":"Melanoma Res"},{"key":"R18-20230902","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CMR.0000000000000155","article-title":"A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab","volume":"25","author":"Carlos","year":"2015","journal-title":"Melanoma Res"},{"key":"R19-20230902","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/2326-6066.CIR-15-0123","article-title":"Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1","volume":"4","author":"Naidoo","year":"2016","journal-title":"Cancer Immunol Res"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008390-201702000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:17:09Z","timestamp":1693624629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201702000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000307","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}